Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatment
Status:
Terminated
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether the effect of treating Candida spp. isolated
in the respiratory tract secretions of patients with a clinical suspicion of ventilator
associated pneumonia (VAP) on clinical outcomes will be feasible and supported by biomarker
data obtained.
Phase:
Phase 2
Details
Lead Sponsor:
Daren K. Heyland
Collaborators:
Pfizer Queen's University The Physicians' Services Incorporated Foundation